Your FDA-friendly roundup of this week’s biggest kratom news: mounting Congressional pressure on the DEA over 7-OH, a new Kansas ban, Rhode Island’s historic reversal, and where natural-leaf kratom stands today.
Congress Ramps Up Pressure on the DEA Over 7-OH
The biggest kratom news this week is the continued, escalating pressure from federal lawmakers urging the Drug Enforcement Administration to act on 7-hydroxymitragynine (7-OH). Members of both the House and Senate have sent letters to the DEA pressing for swift action on concentrated, chemically manipulated 7-OH products—substances that critics say are being falsely marketed as “kratom extracts” despite being far more potent than the natural leaf.
Representative Rob Bresnahan urged the DEA to use its emergency-scheduling authority to halt the spread of high-concentration 7-OH products while a permanent decision is evaluated. On the Senate side, lawmakers including Senator Roger Marshall and Senator Pete Ricketts have separately pressed the FDA and DEA to close what they describe as a regulatory loophole around synthetic 7-OH derivatives.
It is worth underscoring why this distinction matters for everyday shoppers. Concentrated 7-OH is a refined, high-potency compound, while natural kratom leaf contains only trace amounts of it alongside the plant’s primary alkaloid, mitragynine. Lawmakers’ letters this week repeatedly single out the engineered, high-concentration versions sold in formats like rapid-dissolve tablets and gummies—products that bear little resemblance to traditional ground-leaf powder or capsules. Following the news closely helps consumers separate headlines about “kratom” from the narrower category regulators are actually targeting.
For natural-leaf consumers, the key takeaway remains consistent: this federal activity is aimed at concentrated 7-OH, not traditional kratom leaf. The FDA has repeatedly framed its July 2025 scheduling recommendation around high-concentration 7-OH, and any DEA action would still require a formal rulemaking and public comment period.
Kansas Joins the Ban List (Effective July 1, 2026)
At the state level, Kansas has finalized restrictions that take effect July 1, 2026. After Senate Bill 497 cleared the Kansas Senate earlier this year, the substance of that measure was folded into HB 2365, which the governor signed in April 2026. The law schedules kratom’s alkaloids—mitragynine and 7-OH—without establishing a concentration threshold, which effectively restricts kratom products statewide.
Kansas follows Tennessee, which we covered last week, as another state tightening its stance in 2026. If you live in Kansas, review the statute and local guidance before purchasing. KratomWorld.com always encourages customers to confirm the current legal status in their own state.
The Kansas timeline is a useful case study in how kratom legislation can move quickly and change shape along the way. A bill can advance in one chamber, stall, and then resurface as language attached to a different vehicle—exactly what happened when SB 497’s provisions were carried into HB 2365. That is why relying on last year’s information can be risky, and why we track these updates weekly so readers always have a current snapshot.
Quick Snapshot: 2026 State Landscape
As of this week, kratom is fully banned in a handful of states, regulated under Kratom Consumer Protection Act (KCPA) frameworks in over a dozen, and legal without kratom-specific rules in the majority of the country. The patchwork continues to shift month to month, which is exactly why we publish this weekly summary.
Rhode Island’s Historic Ban Reversal
Not all the news runs in one direction. In a development advocates are celebrating, Rhode Island became the first U.S. state to move from a full kratom ban back to a regulated-legal framework. The Rhode Island Kratom Act took effect April 1, 2026, replacing the state’s prior prohibition with a regulated market.
The new framework includes a 21-and-older age requirement, labeling standards, and licensing for retailers—hallmarks of the Kratom Consumer Protection Act model. Supporters point to Rhode Island as proof that sensible regulation, rather than outright prohibition, can protect consumers while preserving access to natural-leaf kratom.
Where Natural-Leaf Kratom Stands Now
Pulling the week’s threads together: federal momentum is concentrated on synthetic and high-concentration 7-OH, individual states continue to set their own rules (some restricting, at least one rolling back a ban), and natural-leaf kratom remains federally legal and unscheduled. The throughline across nearly every credible policy discussion is the distinction between traditional kratom leaf and concentrated 7-OH derivatives.
What does this mean practically if you buy kratom? First, know your state’s status before ordering, since rules differ widely and change throughout the year. Second, favor vendors that are transparent about sourcing and good manufacturing practices. Third, look for clear adults-only (21+) policies and accurate labeling. These are the same standards reflected in Kratom Consumer Protection Act frameworks adopted by a growing number of states, and they align with how responsible retailers operate regardless of where you live.
KratomWorld.com sells natural-leaf kratom powder and capsules only—no concentrated 7-OH products. We follow FDA-friendly practices, restrict sales to adults 21 and older, and emphasize GMP-compliant natural leaf. For ongoing coverage, you can also follow independent reporting at kratom.news.
Zooming out, 2026 has been one of the most active years on record for kratom policy, with simultaneous movement at the federal level and across statehouses. The picture is genuinely mixed: some states are tightening rules around the plant and its derivatives, while others—most notably Rhode Island—are choosing regulation over prohibition. For consumers and responsible vendors alike, the consistent message is that clarity, transparency, and adults-only access tend to win the policy debate. We will keep summarizing the developments that matter most each week so you can stay informed without wading through dozens of headlines.
Shop FDA-Friendly Natural-Leaf Kratom
Looking for trusted, natural-leaf kratom while you stay informed on the news? Explore a few of our most popular powders below—each GMP-compliant and sold to adults 21+.
Red Maeng Da Kratom Powder
From $14.95
Our best-selling natural-leaf red vein, GMP-compliant. Available in powder and capsules.
Green Maeng Da Kratom Powder
From $14.99
A balanced green-vein favorite, finely milled from premium natural kratom leaf. Powder and capsules available.
Red Bali Kratom Powder
From $14.95
Classic red Bali natural-leaf powder, a smooth and dependable staple for everyday kratom enthusiasts.
5 Kilo Bulk Kratom Powder
From $249.95
Build your own 5-kilo bundle from any natural-leaf strains at the best per-kilo value. Powder only.
Frequently Asked Questions
Is natural-leaf kratom being banned by the FDA or DEA?
No. The current federal action targets concentrated, chemically manipulated 7-hydroxymitragynine (7-OH) products, not natural kratom leaf. The FDA has stated its recommendation focuses on high-concentration 7-OH, and any DEA scheduling would go through a public comment period. Natural-leaf kratom powder and capsules remain federally legal. Always verify your own state’s laws.
What is 7-OH and how is it different from kratom?
7-hydroxymitragynine (7-OH) is a minor alkaloid that occurs naturally in trace amounts in the kratom leaf. The products drawing regulatory attention are concentrated or synthetically enhanced 7-OH formulations, which are very different from traditional natural-leaf kratom powder and capsules sold at KratomWorld.com.
Did Kansas ban kratom in 2026?
Kansas enacted restrictions through HB 2365, signed in April 2026 with a July 1, 2026 effective date, that schedule kratom’s alkaloids. Residents in affected states should review current local statutes before purchasing. This article is news and educational information only, not legal advice.
Why did Rhode Island reverse its kratom ban?
Rhode Island became the first U.S. state to move from full prohibition to a regulated framework, effective April 1, 2026, under the Rhode Island Kratom Act. The law adds 21+ age restrictions, labeling, and retailer licensing—an approach advocates cite as evidence that sensible regulation can replace outright bans.
How can I buy kratom responsibly?
Choose vendors that follow GMP practices, restrict sales to adults 21 and older, and clearly label their natural-leaf products. KratomWorld.com sells natural-leaf kratom powder and capsules only and follows FDA-friendly practices. Kratom is not intended to diagnose, treat, cure, or prevent any disease.